Fulcrum Therapeutics (FULC) Stock Forecast for 2024, 2025, 2026. Sell or Buy Prediction







Your Path to Profits: The Best Trading Platforms for New Traders

October 3, 2024 Your Path to Profits: The Best Trading Platforms for New Traders

Welcome to trading! If you’re a newb looking to get to financial freedom, choosing the right trading platform is step one. With so…
Mastering Trading Indicators: Your Essential Toolkit For Success

October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success

Often investors struggle to identify profitable trades consistently. Trading indicators provide essential data to guide trading decisions. This article explains key indicators and…
Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…

Fulcrum Therapeutics (FULC) Stock Forecast for 2024, 2025, 2026. Sell or Buy?

Updated: October 14, 2024 (22:42)

Sector: Healthcare

The share price of Fulcrum Therapeutics, Inc. (FULC) now

Latest session on the 11th of October for
Fulcrum Therapeutics, Inc. is positive
Trading Volume: 651483
Open: 3.28 /  High: 3.5 /  Low: 3.26
What analysts predict: $5.29
52-week High/Low: $13.7 / $2.865
50-Day Moving Average: $6.53 — resistance level today
200-Day Moving Average: $7.75 — resistance level today

Are you interested in Fulcrum Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Fulcrum Therapeutics stock price in 2024, 2025, 2026, 2027, 2028. How much will one Fulcrum Therapeutics share be worth in 2024 - 2028?

When should I take profit in Fulcrum Therapeutics stock? When should I record a loss on Fulcrum Therapeutics stock? What are analysts' forecasts for Fulcrum Therapeutics stock? What is the future of Fulcrum Therapeutics stock? We forecast Fulcrum Therapeutics stock performance using neural networks based on historical data on Fulcrum Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Fulcrum Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Fulcrum Therapeutics shares. This happens once a day.


Historical and forecast chart of Fulcrum Therapeutics stock

The chart below shows the historical price of Fulcrum Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Fulcrum Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Fulcrum Therapeutics is a biopharmaceutical company that develops drugs to treat genetic diseases. The company has developed product candidates to modulate gene expression and potentially treat the underlying cause of these diseases.

Trending Themes in the Healthcare Sector

Fulcrum Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Oct 16 3.66 3.60 3.74 3.83
Oct 17 3.62 3.59 3.71 3.31
Oct 18 3.55 3.51 3.63 3.28
Oct 19 3.43 3.39 3.50 3.16
Oct 20 3.40 3.36 3.45 2.75
Oct 21 3.42 3.37 3.45 2.31
Oct 22 3.47 3.43 3.54 3.15
Oct 23 3.45 3.41 3.55 4.21
Oct 24 3.40 3.32 3.46 4.26
Oct 25 3.31 3.22 3.34 3.66
Oct 26 3.29 3.23 3.33 3.21
Oct 27 3.29 3.23 3.34 3.39
Oct 28 3.33 3.23 3.41 5.62
Oct 29 3.34 3.30 3.43 3.80
Oct 30 3.29 3.25 3.35 3.17
Oct 31 3.31 3.23 3.36 4.06
Nov 01 3.26 3.18 3.30 3.57
Nov 02 3.25 3.20 3.28 2.52
Nov 03 3.26 3.21 3.28 2.23
Nov 04 3.27 3.18 3.34 4.98
Nov 05 3.23 3.21 3.33 3.91
Nov 06 3.29 3.22 3.31 2.82
Nov 07 3.23 3.19 3.32 3.97
Nov 08 3.21 3.15 3.25 3.27
Nov 09 3.27 3.21 3.31 3.18
Nov 10 3.33 3.27 3.36 2.77
Nov 11 3.32 3.22 3.41 6.01
Nov 12 3.38 3.33 3.41 2.56
Nov 13 3.39 3.36 3.43 2.10
Nov 14 3.34 3.24 3.44 6.35

Fulcrum Therapeutics Daily Price Targets


Fulcrum Therapeutics Stock Forecast 10-16-2024.

Forecast target price for 10-16-2024: $3.66.
Positive dynamics for Fulcrum Therapeutics shares will prevail with possible volatility of 3.685%.
Pessimistic target level: 3.60
Optimistic target level: 3.74

Fulcrum Therapeutics Stock Forecast 10-17-2024.

Forecast target price for 10-17-2024: $3.62.
Negative dynamics for Fulcrum Therapeutics shares will prevail with possible volatility of 3.204%.
Pessimistic target level: 3.59
Optimistic target level: 3.71

Fulcrum Therapeutics Stock Forecast 10-18-2024.

Forecast target price for 10-18-2024: $3.55.
Negative dynamics for Fulcrum Therapeutics shares will prevail with possible volatility of 3.172%.
Pessimistic target level: 3.51
Optimistic target level: 3.63

Fulcrum Therapeutics Stock Forecast 10-19-2024.

Forecast target price for 10-19-2024: $3.43.
Negative dynamics for Fulcrum Therapeutics shares will prevail with possible volatility of 3.061%.
Pessimistic target level: 3.39
Optimistic target level: 3.50

Fulcrum Therapeutics Stock Forecast 10-20-2024.

Forecast target price for 10-20-2024: $3.40.
Negative dynamics for Fulcrum Therapeutics shares will prevail with possible volatility of 2.676%.
Pessimistic target level: 3.36
Optimistic target level: 3.45

Fulcrum Therapeutics Stock Forecast 10-21-2024.

Forecast target price for 10-21-2024: $3.42.
Positive dynamics for Fulcrum Therapeutics shares will prevail with possible volatility of 2.262%.
Pessimistic target level: 3.37
Optimistic target level: 3.45

FULC (FULC) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Nov. 3.49 3.03 3.93 22.87
Dec. 3.24 2.76 3.62 23.93

Fulcrum Therapeutics forecast for this year


Fulcrum Therapeutics Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $3.48696. Pessimistic: $3.03. Optimistic: $3.93


Fulcrum Therapeutics Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $3.2359. Pessimistic: $2.76. Optimistic: $3.62



Fulcrum Therapeutics (FULC) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 3.49 3.10 3.87 19.89
Feb 3.05 2.59 3.23 19.81
Mar 2.52 2.27 2.64 13.93
Apr 2.62 2.46 2.89 14.91
May 2.85 2.48 3.09 19.59
Jun 2.69 2.36 3.01 21.47
Jul 2.48 2.30 2.84 19.02
Aug 2.48 2.17 2.60 16.76
Sep 2.03 1.71 2.19 21.71
Oct 2.23 1.97 2.52 21.59
Nov 2.10 1.83 2.44 24.83
Dec 1.89 1.72 2.15 19.72

Fulcrum Therapeutics (FULC) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 2.11 1.97 2.40 17.89
Feb 2.11 1.96 2.39 18.17
Mar 2.39 2.01 2.69 25.18
Apr 2.79 2.62 3.07 14.36
May 2.70 2.27 2.85 20.30
Jun 2.43 2.20 2.59 14.98
Jul 2.22 1.93 2.41 19.96
Aug 2.16 2.05 2.36 13.16
Sep 1.76 1.61 1.88 14.45
Oct 1.91 1.68 2.08 18.93
Nov 2.08 1.91 2.32 17.77
Dec 2.30 2.17 2.47 12.13

Fulcrum Therapeutics information and performance

Fulcrum Therapeutics Address

26 LANDSDOWNE STREET, CAMBRIDGE, MA, US

Market Capitalization: 217 155 000 $

Market capitalization of the Fulcrum Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of FULC shares in the company outstanding by the market price of one share.

EBITDA: -30 880 000 $

EBITDA of Fulcrum Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.34

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 89.91
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 117.4

Enterprise Value (EV) /Revenue

EV To EBITDA: -3.095

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 62401000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.